{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:28:15Z","timestamp":1792787295926,"version":"4.5.0"},"reference-count":33,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T00:00:00Z","timestamp":1689033600000},"content-version":"unspecified","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Hassenfeld Scholar Award"},{"DOI":"10.13039\/501100015498","name":"Innov\u00e1ci\u00f3s \u00e9s Technol\u00f3giai Miniszt\u00e9rium","doi-asserted-by":"publisher","award":["2020-4.1.1.-TKP2020"],"award-info":[{"award-number":["2020-4.1.1.-TKP2020"]}],"id":[{"id":"10.13039\/501100015498","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015498","name":"Innov\u00e1ci\u00f3s \u00e9s Technol\u00f3giai Miniszt\u00e9rium","doi-asserted-by":"publisher","award":["NVKP_16-1\u20132016-0017"],"award-info":[{"award-number":["NVKP_16-1\u20132016-0017"]}],"id":[{"id":"10.13039\/501100015498","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015498","name":"Innov\u00e1ci\u00f3s \u00e9s Technol\u00f3giai Miniszt\u00e9rium","doi-asserted-by":"publisher","award":["\u00daNKP-22-4-II-SE"],"award-info":[{"award-number":["\u00daNKP-22-4-II-SE"]}],"id":[{"id":"10.13039\/501100015498","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TA 1438\/1-2. T"],"award-info":[{"award-number":["TA 1438\/1-2. T"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"A. Curt Greer and Pamela Kohlberg, the Michael and Kathryn Park Endowed Chair in Cardiology"},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["NCT04430712"],"award-info":[{"award-number":["NCT04430712"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL130539, R01HL137562, R01HL159187, K24HL150238"],"award-info":[{"award-number":["R01HL130539, R01HL137562, R01HL159187, K24HL150238"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2023,6,25]]},"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients with lung cancer face a heightened risk of atherosclerosis-related cardiovascular events. Despite the strong scientific rationale, there is currently a lack of clinical evidence examining the impact of immune checkpoint inhibitors (ICIs) on the advancement of atherosclerosis in patients with lung cancer. The objective of our study was to investigate whether there is a correlation between ICIs and the accelerated progression of atherosclerosis among individuals with lung cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this case\u2013control (2:1 matched by age and gender) study, total, non-calcified, and calcified plaque volumes were measured in the thoracic aorta using sequential contrast-enhanced chest CT scans. Univariate and multivariate rank-based estimation regression models were developed to estimate the effect of ICI therapy on plaque progression in 40 cases (ICI) and 20 controls (non-ICI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The patients had a median age of 66 years (IQR: 58\u201369), with 50% of them being women. At baseline, there were no significant differences in plaque volumes between the groups, and their cardiovascular risk profiles were similar. However, the annual progression rate for non-calcified plaque volume was 7 times higher in the ICI group compared with the controls (11.2% vs 1.6% per year, p=0.001). Conversely, the controls showed a greater progression in calcified plaque volume compared with the ICI group (25% vs 2% per year, p=0.017). In a multivariate model that considered cardiovascular risk factors, the use of an ICI was associated with a more substantial progression of non-calcified plaque volume. Additionally, individuals treated with combination ICI therapy exhibited greater plaque progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>ICI therapy was associated with more non-calcified plaque progression. These findings underscore the importance of conducting studies aimed at identifying the underlying mechanisms responsible for plaque advancement in patients undergoing ICI treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT04430712\">NCT04430712<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2023-007307","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T21:56:15Z","timestamp":1689112575000},"page":"e007307","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":45,"title":["Impact of immune checkpoint inhibitors on atherosclerosis progression in patients with lung cancer"],"prefix":"10.1136","volume":"11","clinical-trial-number":[{"clinical-trial-number":"nct04430712","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04430712","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1355-5318","authenticated-orcid":false,"given":"Zsofia Dora","family":"Drobni","sequence":"first","affiliation":[{"name":"Cardiovascular Imaging Research Center (CIRC), Department of Radiology and Division of Cardiology, Massachusetts General Hospital Department of Radiology, Boston, Massachusetts, USA"},{"name":"Heart and Vascular Center, Semmelweis University, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Gongora","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Taron","sequence":"additional","affiliation":[{"name":"Department of Radiology, Medical Center, University of Freiburg, Freiburg im Breisgau, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giselle A","family":"Suero-Abreu","sequence":"additional","affiliation":[{"name":"Cardiovascular Imaging Research Center (CIRC), Department of Radiology and Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Karady","sequence":"additional","affiliation":[{"name":"Cardiovascular Imaging Research Center (CIRC), Department of Radiology and Division of Cardiology, Massachusetts General Hospital Department of Radiology, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah K","family":"Gilman","sequence":"additional","affiliation":[{"name":"Cardiovascular Imaging Research Center (CIRC), Department of Radiology and Division of Cardiology, Massachusetts General Hospital Department of Radiology, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sama","family":"Supraja","sequence":"additional","affiliation":[{"name":"Cardiovascular Imaging Research Center (CIRC), Department of Radiology and Division of Cardiology, Massachusetts General Hospital Department of Radiology, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Nikolaidou","sequence":"additional","affiliation":[{"name":"Cardiovascular Imaging Research Center (CIRC), Department of Radiology and Division of Cardiology, Massachusetts General Hospital Department of Radiology, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Leeper","sequence":"additional","affiliation":[{"name":"Department of Surgery, Stanford University, Stanford, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9la","family":"Merkely","sequence":"additional","affiliation":[{"name":"Heart and Vascular Center, Semmelweis University, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pal","family":"Maurovich-Horvat","sequence":"additional","affiliation":[{"name":"Department of Radiology, Semmelweis University, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borek","family":"Foldyna","sequence":"additional","affiliation":[{"name":"Cardiovascular Imaging Research Center (CIRC), Department of Radiology and Division of Cardiology, Massachusetts General Hospital Department of Radiology, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas G","family":"Neilan","sequence":"additional","affiliation":[{"name":"Cardiovascular Imaging Research Center (CIRC), Department of Radiology and Division of Cardiology, Massachusetts General Hospital Department of Radiology, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,7,11]]},"reference":[{"key":"2025100311373453000_11.7.e007307.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.02.065"},{"key":"2025100311373453000_11.7.e007307.2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.93.1.34"},{"key":"2025100311373453000_11.7.e007307.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.9.1071"},{"key":"2025100311373453000_11.7.e007307.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110874"},{"key":"2025100311373453000_11.7.e007307.5","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2014.60"},{"key":"2025100311373453000_11.7.e007307.6","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar4060"},{"key":"2025100311373453000_11.7.e007307.7","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.0423","article-title":"Estimation of the percentage of US patients with cancer who are eligible for immune Checkpoint inhibitor drugs","volume":"3","author":"Haslam","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2025100311373453000_11.7.e007307.8","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-021-01056-8"},{"key":"2025100311373453000_11.7.e007307.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2109970"},{"key":"2025100311373453000_11.7.e007307.10","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0590-4"},{"key":"2025100311373453000_11.7.e007307.11","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aay1863","article-title":"Targeted deletion of PD-1 in myeloid cells induces antitumor immunity","volume":"5","author":"Strauss","year":"2020","journal-title":"Sci Immunol"},{"key":"2025100311373453000_11.7.e007307.12","doi-asserted-by":"publisher","DOI":"10.1172\/JCI31344"},{"key":"2025100311373453000_11.7.e007307.13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s40425-018-0382-2","article-title":"The society for Immunotherapy of cancer consensus statement on Immunotherapy for the treatment of non-small cell lung cancer (NSCLC)","volume":"6","author":"Brahmer","year":"2018","journal-title":"J Immunotherapy Cancer"},{"key":"2025100311373453000_11.7.e007307.14","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1161\/CIRCULATIONAHA.120.049981","article-title":"Association between immune Checkpoint inhibitors with cardiovascular events and Atherosclerotic plaque","volume":"142","author":"Drobni","year":"2020","journal-title":"Circulation"},{"key":"2025100311373453000_11.7.e007307.15","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijcard.2021.07.054","article-title":"Impact of cancer diagnosis on causes and outcomes of 5.9 million US patients with cardiovascular admissions","volume":"341","author":"Matetic","year":"2021","journal-title":"Int J Cardiol"},{"key":"2025100311373453000_11.7.e007307.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1509155"},{"key":"2025100311373453000_11.7.e007307.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1201161"},{"key":"2025100311373453000_11.7.e007307.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2013.01.306"},{"key":"2025100311373453000_11.7.e007307.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2011.02.056"},{"key":"2025100311373453000_11.7.e007307.20","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-014-3253-3"},{"key":"2025100311373453000_11.7.e007307.21","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1016\/S2352-3018(14)00032-0","article-title":"Effects of Statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with Subclinical Atherosclerosis: a randomised, double-blind, placebo-controlled trial","volume":"2","author":"Lo","year":"2015","journal-title":"Lancet HIV"},{"key":"2025100311373453000_11.7.e007307.22","unstructured":"Foundation for Statistical Computing . Team RC: R: A language and environment for statistical computing. Vienna, Austria, 2017."},{"key":"2025100311373453000_11.7.e007307.23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1609214"},{"key":"2025100311373453000_11.7.e007307.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2018.04.015"},{"key":"2025100311373453000_11.7.e007307.25","article-title":"Cardiotoxicity from immune Checkpoint inhibitors","volume":"25","author":"Michel","year":"2019","journal-title":"Int J Cardiol Heart Vasc"},{"key":"2025100311373453000_11.7.e007307.26","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.18.2217"},{"key":"2025100311373453000_11.7.e007307.27","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.121.013348","article-title":"Heritability of coronary artery disease: insights from a classical twin study","volume":"15","author":"Drobni","year":"2022","journal-title":"Circ Cardiovasc Imaging"},{"key":"2025100311373453000_11.7.e007307.28","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jaccao.2022.11.011","article-title":"Atherosclerosis with immune Checkpoint inhibitor therapy: evidence, diagnosis, and management: JACC: Cardiooncology state-of-the-art review","volume":"4","author":"Suero-Abreu","year":"2022","journal-title":"JACC CardioOncol"},{"key":"2025100311373453000_11.7.e007307.29","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000138"},{"key":"2025100311373453000_11.7.e007307.30","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000143933.20616.1b"},{"key":"2025100311373453000_11.7.e007307.31","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.111.224709"},{"key":"2025100311373453000_11.7.e007307.32","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.115.306848"},{"key":"2025100311373453000_11.7.e007307.33","doi-asserted-by":"crossref","DOI":"10.1093\/immadv\/ltab014","article-title":"Association between incidental Statin use and Skeletal Myopathies in patients treated with immune Checkpoint inhibitors","volume":"1","author":"Drobni","year":"2021","journal-title":"Immunother Adv"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2023-007307","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T18:37:45Z","timestamp":1759516665000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2023-007307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":33,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7,11]]},"published-print":{"date-parts":[[2023,7]]}},"alternative-id":["10.1136\/jitc-2023-007307"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2023-007307","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7]]}}}